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Deﬁnitive hematopoiesisVertebrate hematopoiesis is characterized by two evolutionally conserved phases of development, i.e.,
primitive hematopoiesis, which is a transient phenomenon in the early embryo, and deﬁnitive
hematopoiesis, which takes place in the later stages. Beni fuji (bef) was originally isolated as a medaka
mutant that has an apparently reduced number of erythrocytes in its peripheral blood. Positional cloning
revealed that the befmutant has a nonsense mutation in the c-myb gene. Previous studies have shown that c-
myb is essential for deﬁnitive hematopoiesis, and c-myb is now widely used as a marker gene for the onset of
deﬁnitive hematopoiesis. To analyze the phenotypes of the bef mutant, we performed whole-mount in situ
hybridization with gene markers of hematopoietic cells. The bef embryos showed decreased expression of α-
globin and l-plastin, and a complete loss of mpo1 and rag1 expression, suggesting that the bef embryos had
defects not only in erythrocytes but also in other myeloid cells, which indicates that their deﬁnitive
hematopoiesis was aberrant. Interestingly, we observed a diminution in the number of primitive
erythrocytes and a delay in the emergence of primitive macrophages in the bef embryos. These results
suggest that c-myb also functions in the primitive hematopoiesis, potentially demonstrating a link between
primitive and deﬁnitive hematopoiesis.formation, Tokyo Institute of
ma, 226-8501, Japan. Fax: +81
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Vertebrate hematopoiesis is characterized by 2 evolutionally
conserved phases of development, i.e., primitive hematopoiesis and
subsequent deﬁnitive hematopoiesis (Carradice and Lieschke, 2008;
Davidson and Zon, 2004; Martinez-Agosto et al., 2007). The primitive
hematopoiesis is a transient hematopoiesis that takes place during early
embryonic development. In this primitive hematopoiesis, 2 blood cell
populations are produced, primitive erythrocytes and primitive macro-
phages, from an independent mesodermal progenitor (Carradice and
Lieschke, 2008; Davidson and Zon, 2004). In mouse embryos, the
primitive hematopoiesis takes place at the surface of the yolk sac
(Martinez-Agosto et al., 2007; Mikkola and Orkin, 2006); whereas, in
zebraﬁsh embryos, the primitive erythrocytes arise from the posterior
lateral mesoderm, which subsequently becomes the intermediate cell
mass (ICM) formed in the tail. The primitive macrophages in zebraﬁsh
arise from the anterior lateral mesoderm, and diffuse throughout the
surface of the yolk sac periphery to the head (Carradice and Lieschke,
2008; Davidson and Zon, 2004).On the other hand, the deﬁnitive hematopoiesis continues through-
out life. Its initiation is deﬁned by the emergence of the hematopoietic
stem cell, which is the common progenitor of all blood cells:
erythrocytes, myelocytes, and lymphocytes (Davidson and Zon, 2004;
Martinez-Agosto et al., 2007). In mouse embryos, the hematopoietic
stem cells appear ﬁrst in the aorta-gonad-mesonephros (AGM); and via
the fetal liver, the ultimate hematopoiesis takes place in the bone
marrow (Martinez-Agosto et al., 2007; Mikkola and Orkin, 2006). In
zebraﬁsh embryos, the hematopoietic stem cells are reported to emerge
from the ventral wall of the dorsal aorta, which is termed the teleost
“AGM;”and the ultimate deﬁnitive hematopoietic site settles in the
pronephros, which subsequently forms the kidney (Bertrand et al.,
2008; Bertrand et al., 2007; Bertrand and Traver, 2009; Carradice and
Lieschke, 2008; Davidson and Zon, 2004; Murayama et al., 2006).
Recently, another population of cells involved in deﬁnitive hematopoi-
esis was found in the zebraﬁsh. These cells are termed EMPs
(erythromyeloid progenitors), and they generate erythrocytes, macro-
phages and granulocytes before the AGM is formed. EMPs are located at
the posterior aspect of the embryonic body, and an analogous
population is also found in mice (Bertrand et al., 2007; Bertrand and
Traver, 2009).
The c-myb gene, which encodes a 75-kDa transcription factor, was
originally identiﬁed as the proto-oncogene of an avian myeloblastic
leukemia, and is reported to function mainly in cell proliferation
(Weston and Bishop, 1989; Wolff, 1996). Its expression is observed
Fig. 1. The bef mutant produces small number of erythrocytes. (A) View of st35 medaka
embryos, wild type (WT) and Beni fuji (bef). At lowmagniﬁcation, the yolk sac veins inWT
embryos are observed as red lines,whereas the veins are transparent in bef embryos. (B, C)
Magniﬁed view of the Cuvierian duct. bef displays a drastic reduction in the number of
circulating blood cells. (D, E) Erythrocytes in live st35 WT and bef embryos crossed with
α-globinGFP transgenicmedaka. bef shows a reduced number of erythrocytes, though the
blood cells are not completely lost. Scale bars indicate 500 μm (A, D, E) and 10 μm (B, C).
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and gradually decreases as the cells differentiate. Its function in vivo has
been mainly characterized from the observation of c-myb-deﬁcient
mice, demonstrating a defect in the deﬁnitive hematopoiesis (Greig
et al., 2008). However, because of the frequent changes in the
hematopoietic tissue during development, and because the embryos
develop in utero, further detailed observation in mice is thus limited.
Recently, the zebraﬁsh has been utilized as an alternative model
organism for hematopoietic studies, due to its suitability for visual live
inspection anddirectmanipulation of embryonic tissues (Weinstein et al.,
1996). However, although the expression pattern of c-myb has been
thoroughly documented and its transgenic line has been generated in
zebraﬁsh (Bertrand et al., 2008; North et al., 2007; Thisse and Thisse,
2005), a viable c-myb zebraﬁsh mutant that can develop through the
hematopoietic stage has not been obtained yet (Thompson et al., 1998),
which limits clariﬁcation of the comprehensive role of c-myb during
embryonic hematopoiesis.
In our laboratory, we made an approach by using medaka, another
teleost that shares the same experimental advantages with the
zebraﬁsh, but possesses a smaller-sized genome and established inbred
strains, which are powerful advantages for the application of forward
genetics (Ishikawa, 2000;Wittbrodt et al., 2002). In a previous study,we
carried out ENU mutagenesis with medaka embryos, and identiﬁed
8 medaka mutants that display defects in embryonic hematopoiesis
(Tanaka et al., 2004).
In this present study, we further characterized the Beni fuji (bef)
mutant ofmedaka,whichapparently displayed a reducednumberof red
blood cells, but in which other tissues were formed normally. From
positional cloning,wediscovered thatbefhad anonsensemutation in its
c-myb gene. From an evaluation using known hematopoietic markers,
we found out that bef completely lacked or harbored very small
numbers of blood cells produced during deﬁnitive hematopoiesis.
Observations carried out in the early stages revealed that bef also had a
smaller number of primitive erythrocytes, and showed a delay in the
emergence of anterior macrophages. Thus, these results indicate that
c-myb functions in both primitive and deﬁnitive hematopoiesis.
Materials and methods
Medaka strain
The medaka Cab strain (Loosli et al., 2000) was utilized as the wild
type for all studies reported herein.Medaka embryos were incubated at
28 °C and staged according to the Iwamatsu stages (Iwamatsu, 2004).
Positional cloning
Positional cloningwas carried out in the ordinary procedure which
was previously described (Hibiya et al., 2009). We used established
medaka polymorphicmarkersMF01SSA047H03 and OLc1103 (Naruse
et al., 2000) and newly designed restriction fragment length
polymorphism (RFLP) markers [127-1: 5'-agctgaagttgcatcatcgtg-3',
5'-tggattgggtggtgttcatc-3'/MspI ], [ 080421_1: 5'-cacagaggtcagtagagg-
gag-3' , 5'-ctctgctgaacatcatgtgg-3'/Hha I] , [071129_4: 5'-
gctggtttgttgtgttataaagg-3', 5'-gtagatgaacaacgtttaagcc-3'/EcoRI],
[080421_2: 5'-gaagttgtacgcagctcgg-3', 5'-gaaggtcaatgagatgcaactc-3'/
HaeIII] and [071129_5: 5'-cttgaacgtgcatttagacc-3', 5'-gaaggacaaatcaa-
taacagcag-3'/HinfI]. The cDNAs of c-myb (AB114037) from themedaka
embryos were ampliﬁed in 2 separate regions of 1300 base pairs (bp)
to verify themutated sequence. The genomic PCRwas carried out with
primers[ 5'-cgaagaggaggacagaatcatc-3', 5'-gtgcgtgtcagaaatgtaagc-3'],
digested with the restriction enzyme TaqI, which only cleaves the
wild-type allele and not the mutant allele. The primers were designed
to amplify a 684-bp genomic region; and the digested products were
482 bp and 162 bp.Whole-mount RNA in situ hybridization and transgenic lines
Whole-mount RNA in situ hybridization (WISH) was performed
with DIG-labeled antisense RNA probes following the procedure
previously described (Inohaya et al., 1995; Inohaya et al., 1999).
PCR primers used for each gene were [ c-myb; 5'-cgaagaggaggacagaat-
catc-3', 5'-gtgcgtgtcagaaatgtaagc-3'], [ lmo2; 5'-cccgtggatgaggtgctgcag-
3', 5'-acagaagtgtttctgacaggc-3'], [pu.1;5'-agaccaacttcacagagctgc-3', 5'-
cttcatcactgaactgatacgtc-3'], [mpo1;5'-ggatgcgcagcacaagcccgacttc-3' and
5'-gtcagtgttgtcacagatgattttg-3'], [rag1;5'-cgctgtgtgtttggctatcc-3', 5'-
cgttcaagattctcgtcgtg-3' for] and [α-globin; 5'-gacaagatgaccagtctctctgc-
3', 5'-ctcttcttcaatgacttggac'-3'] which was described as em.α-0
(Maruyama et al., 2002). The primers [ l-plastin: 5'-ctgaacgagctctt-
caaggcg-3', 5'-ttaggctctcttcatgccgcg-3'] were designed by Chatani et al.
(manuscript in preparation). The α−globin-GFP transgenic line was
established as α0 (up-1) GFP (Maruyama et al., 2007), and the ﬂi1-GFP
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of Bath, UK).
Frozen section
WISHperformed embryoswere rinsed in PBS, ﬁxedwith 4% PFA/PBS
for 30 min at room temperature, processed with 15% sucrose/PBS. The
processed embryoswere embedded in12%gelatin, 15% sucrose/PBS and
placed at 4 °C overnight. The embedded samples were frozen at−20 °C
and sectioned at 20 μm.
RT-PCR analysis
RT-PCR was carried out with 2 μg of total mRNA prepared from 22
embryos each from WT and bef embryos at st27. Total mRNA was
extracted by using ISOGEN (NIPPON GENE CO., LTD, Tokyo, Japan)
according to the manufacturer's protocol. 2 μg of total mRNA was used
for reverse-transcription, and the cDNA was synthesized by using a
cDNA synthesis kit with AMV Reverse Transcriptase (TAKARA BIO INC.,
Siga, Japan). Primers used are [ runx1; 5'-cacgcctccctccacgtc -3', 5'-
gagaactgctgtggctggactc-3'] and [ β-actin; 5'-actacctcatgaagatcctg-3', 5'-
tgctgatccacatctgctg-3'] described previously (Katagiri et al., 1997). PCR
was carried out with KOD-Plus DNA Polymerase (TOYOBO CO., LTD,
Osaka, Japan) in the followingconditions; annealing temperature: 60 °C,
number of cycles: 30.Fig. 2. The bef locus encodes c-myb. (A) Positional cloning of the gene disrupted by bef mut
down the candidate region to 333 kb, which included the transcription factor c-myb. (B) c
mutation exists at the 603th base, which alters the TaqI digestion site. (C) Genomic PCR of c-
but does not digest any of them from bef embryos (4 samples in the middle), which indicat
structure of WT and bef embryos. Owing to the nonsense mutation, bef lacks the transactivResults
The bef mutant produces a small number of erythrocytes
Beni fuji (bef) is a recessive mutant characterized by its severe deﬁcit
of circulating blood cells. bef is lethal, but survives until 1 or 2 days after
hatching and shows normal morphology in other tissues. At stage 35
(st35) of wild-type (WT) embryos, coiled veins termed the Cuvierian
ducts (Iwamatsu, 2004) cover the surface of the yolk sac and the
circulating blood cells in them appear as a red line at low resolution,
whereas in bef, the veins appear as a transparent line (Fig. 1A). Magniﬁed
view revealed that this difference was due to a reduced number of blood
cells circulating inside the veins (Fig. 1B, C). To visualize the erythrocytes,
we crossed the bef heterozygotes with α-globin GFP transgenic medaka
that expressed GFP speciﬁcally in their erythrocytes (Maruyama et al.,
2007). As expected, bef showed an abated GFP expression, though not a
complete loss (Fig. 1E). These results indicate that befharboredonly a very
small number of erythrocytes.
The bef locus encoded c-myb
To identify the genomic mutation in bef, we carried out positional
cloning. The bef locus was genetically mapped to the medaka linkage
group 24 (LG24) by bulked segregate analysis with theM-marker system
(Kimura et al., 2004). Geneticmappingwith 878meioses narroweddownation. The mutation was mapped on medaka LG24. Analysis of 878 meioses narrowed
DNA sequence of c-myb obtained from WT and bef embryos. In bef, a G to T nonsense
myb gene. TaqI digests all of the DNA obtained fromWT embryos (4 samples on the left)
es the direct linkage between the bef locus and the c-myb mutation. (D) C-myb protein
ation and negative regulatory domains.
136 A. Moriyama et al. / Developmental Biology 345 (2010) 133–143the responsible region to 333 kbp (Fig. 2A). By sequencing the cDNAs in
the candidate genes in this region,we found aG to Tnonsensemutation at
the 603th base of the c-myb gene (Fig. 2B).
To directly conﬁrm the linkage between the bef phenotype and the
c-mybmutation, we carried out a genomic PCR. As displayed in Fig. 2C,
all DNA samples obtained from the embryos of the wild-type Cab strain
showed the lower 2 bands, which indicates that they did not have the
mutation. In contrast, all DNA samples from bef embyos showed a single
band, indicating that they had the mutation. The littermates with no
phenotype showed either all 3 bands, i.e., the heterozygous allele, or the
lower 2 bands, i.e., theWT allele. Thus, this result demonstrates a direct
correlation between the bef phenotype and the mutation of c-myb.
As the nonsense mutation altered the 192th glutamic acid residue
into a stop codon, bef embryos would be expected to lack the
transactivation domain and negative regulatory domain that are
required for the regular transcription activity of the C-myb protein
(Fig. 2D), which mutation is reported to be functionally equivalent to
null in mice (Greig et al., 2008; Ramsay and Gonda, 2008).Primitive hematopoiesis deﬁned by the expression of lmo2, α-globin
In order to understand the phenotype of bef, we attempted to
deﬁne the primitive and deﬁnitive hematopoiesis inmedaka, and then
to demonstrate in which program the bef mutant presents defect.Fig. 3. Primitive hematopoiesis deﬁned by the expression of lmo2 andα-globin. Expressions ofα
the early stages ofWT embryos (A–J, K–T, respectively). The expression at the posterior lateralm
expression of lmo2 at the anterior lateral mesoderm is indicated by arrows (K, P). Asterisks indWe ﬁrstly examined the expression of an embryonic erythrocyte
marker, α-globin (Maruyama et al., 2002; Sakamoto et al., 2004), and a
marker for progenitors of blood cells and vascular cells, lmo2 (Hsia and
Zon, 2005) in the early embryonic stages of medaka by WISH to deﬁne
primitive hematopoiesis. In the medaka WT embryos, weak α-globin
expressionwasﬁrst observedbilaterally in theposterior lateralmesoderm
at st21 (34 hpf; 6-somite stage; Fig. 3B, G), and became very obvious at
st22 in the ICM (Fig. 3C, H, black arrowhead). At st23, the expression ofα-
globinwas detectable in 2 layers (Fig. 3I, J), which possibly indicates the 2
distinctive erythrocytepopulations, i.e., theprimitiveerythrocytes and the
deﬁnitive erythrocytes. The lmo2 expression appeared at st20 previous to
α-globin, and showed strong bilateral expression in the anterior and
posterior lateral mesoderm (Fig. 3K, P, black arrowheads and white
arrowheads, respectively), which is presumed to reﬂect the primitive
hematopoietic progenitors, i.e., the anterior macrophage progenitors and
theposterior erythrocyteprogenitors. Theposteriorbilateral expressionof
lmo2 fused at st22 and showed a similar expression with that of α-globin
in 2 layers (Fig. 3R, S, T, white arrowhead). Expression of lmo2 in vascular
cells was also observed (Fig. 3L–O, asterisk).
The expression of c-myb was detectable in primitive hematopoiesis as well
as in deﬁnitive hematopoiesis
We next examined the expression pattern of c-myb during
embryogenesis. We found the ﬁrst c-myb expression at st20 (31.5-globin, an erythrocytemarker, and lmo2, amarker of blood/vascular progenitormarker, at
esoderm is indicated by arrowheads, black forα-globin andwhite for lmo2 (A–T); and the
icate the junction of the Cuverian ducts to show the orientation of embryos (K–T).
137A. Moriyama et al. / Developmental Biology 345 (2010) 133–143hpf; 4-somite stage; Fig. 4A, B). Similar to the expression of lmo2, the
c-myb expression was observed in bilateral stripes of the anterior and
posterior lateral mesoderm (Fig. 4A–D, arrows), in the putative region
of primitive hematopoiesis. The posterior bilateral c-myb expressions
fused at themidline and ultimately formed the caudal 2 layers (Fig. 4F,
H, J arrowheads). The ventral layer subsequently became the ICM
(Fig. 4F, H, J, M white arrowheads), and the dorsal layer subsequentlyFig. 4. Expression of c-myb. Expression of c-myb in the early-stage (A–J) and late-stage embry
observed bilaterally in the anterior (A–Dblack arrows) and posteriormesoderm(A–Dwhite arr
arrowheads). The ventral layer indicated in white arrowheads is the ICM (F, H, J, M), and th
progenitors (F,H, J, K–P).At st27, c-myb expressionwas observed in the eyes (K, L black arrows),
The expression of c-myb in the prospective deﬁnitive area remained beyond the onset of bloodbecame the prospective region for deﬁnitive progenitors (DPs)
located right ventral to the notochord and dorsal aorta (Fig. 4F, H,
J–P black arrowheads). At st27 (58hpf; 24-somite stage), c-myb
expression was observed in the eyes (Fig. 4K, L black arrows), in the
blood vessels (Fig. 4K, L asterisks), and in the deﬁnitive area (Fig. 4K, L
black arrowheads). The expression of c-myb in the prospective
deﬁnitive area remained beyond the onset of blood circulationos (K–P). (yolk-sac removed in “M–P”) At the early stages, the expression of c-myb was
ows). From st22–24, the expressionwas observed in the 2 layers of the caudal region (F, H, J
e dorsal layer indicated in black arrowheads is the prospective region for the deﬁnitive
bloodvessels (K, L asterisks), and in theprospective deﬁnitive area (K, L black arrowheads).
circulation (M–P black arrowheads).
138 A. Moriyama et al. / Developmental Biology 345 (2010) 133–143(Fig. 4M–P black arrowheads), continually observed at st28, 29 and
became invisible at st30 (82hpf) (data not shown).
Comparison of the caudal expression of c-myb, lmo2 and α-globin
To precisely validate the caudal expression of c-myb, lmo2, and α-
globin,we examined the frozen section of the WISH-performed embryos
(Fig. 5A–P). At st21, c-myb and lmo2 expressions showed a single layer
(Fig. 5A, C), and the sagittal section indicated that the these 2 expressions
were located ventrally (Fig. 5B, D), and later they were fused (data not
shown). At st22, c-myb and lmo2 expressions were observed in 2 layers
(Fig. 5E, G), the ventral site and the dorsal site in the sagittal section
(Fig. 5F, H), whereas the expression of α-globinwas observed only at the
ventral site (Fig. 5J). At st23, the expression of α-globinwas also detected
in the dorsal site (Fig. 5P), which overlappedwith that of c-myb and lmo2
(Fig. 5L, N), and these 3 expressions relatively increased, compared with
those in st22 or in the ventral site of st22. Thus, As shown in Fig. 5Q, this
transition of the hematopoietic markers indicates that the erythrocytes
progenitors ﬁrst produced erythrocytes in the ventral site, which is the
ICM, and subsequently produced them in the ventral site, which is the
deﬁnitive area.
Erythrocytes in bef
We then characterized the phenotype of bef from the view point of
which hematopoietic lineage was affected by the absence of c-myb. ToFig. 5. Comparison of the caudal expression of c-myb, lmo2 andα-globin.Comparison of c-myb, lm
transition of the hematopoieticmarker expression (Q). The section analyses (B, D, F, H, J, L, N, P)
lmo2 expressionswere observed ventrally (B, D), and at st22 generated 2 layers of the dorsal site
erythrocytes (α-globin-positive cells) in ICM (Fig. 4Q lower layer), and latter subsequently prod
(A, C, E, G, I, K, M, O) and 50 μm (B,D,F,H,J,L,N,P).determine what types of blood cells were present in bef, we performed
WISH to detect typical hematopoietic genes. First we examined the
expression of α-globin in bef, at st24 (44 hpf; heart beating stage), st27
(58 hpf; 24-somite stage), and st32 (101 hpf; somite completion stage),
to identify which of these 2 populations was affected owing to the
absence of c-myb.
At st24, robust expression in2 layerswas observed, prospectively the
ventral ICM-derived erythrocytes (Fig. 6A, C, black arrowheads) and the
prospective dorsal DP-derived erythrocytes (Fig. 6A, C, black arrows). At
st27 and 32, broad expression of α-globinwas observed inside the blood
vessel reﬂecting the circulatingerythrocytes (Fig. 6E–L). Inbefmutant, at
st24, the DP-derived erythrocytes were completely absent (Fig. 6B, D,
white arrowheads); on the contrary, the expression in the ICM clearly
remained, although the size of the ICM seemed to be slightly smaller
(Fig. 6B, D, white arrow). At st27 and 32, the expression of α-globin
showed a signiﬁcant decrease; although the expression always
remained, but at a very low level (Fig. 6F, J, H, L). This remaining α-
globin expression reﬂects the very few remaining erythrocytes observed
in bef (Fig. 1A, C, E), are possibly presumed to be the erythrocytes
produced in the primitive hematopoiesis. Previously, Tanaka et al.
(2004) suggested that the erythrocytes in bef retain the normal
morphology and normal function, as concluded from o-Dianisidine
staining.
Interestingly, in bef, the α-globin expression in ICM seemed to
remain at the subsequent stages (Fig. 6F, H, L, asterisks); whereas the
ICM structurewas already diminished in theWTembryos (Fig. 6E, G, K).o2, andα-globin, in theposterior lateralmesoderm (A–P) and a diagram that indicates the
were performed fromWISH samples (A, C, E, G, I, K,M, O), respectively. At st21, c-myb and
and the ventral site. The progenitor cells (c-myb and lmo2-positive cells) ﬁrst produce the
uce the erythrocytes in the deﬁnitive area (Fig. 4Q, upper layer). Scale bars indicate 250 μm
Fig. 6. Erythrocytes in bef. Expression of α-globin, at st24, st27, and st32, observed at the lateral and dorsal sites (A–L). At st24, 2 distinctive erythrocyte populations are observed in
theWT embryos, the prospective DP-derived erythrocytes (A, black arrowhead), and the ICM primitive erythrocytes (A, black arrow). In bef, the prospective DP-derived erythrocytes
are completely absent (B, white arrowhead, whereas the ICM primitive erythrocytes are left (B, white arrow). At st27 and 32, the expression of α-globin shows a signiﬁcant decrease
in bef, though the expression always remains at a very low level (E–L). In bef, the structure of ICM is continually observed in the subsequent stages (F, H, L, asterisks). Scale bars
indicate 250 μm.
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From previous studies, macrophages are also known to consist of 3
distinct populations; the primitive macrophages, the EMP-derived
macrophages, and the HSC-derived macrophages (Bertrand et al.,
2007; Carradice and Lieschke, 2008; Davidson and Zon, 2004; Jin
et al., 2009). In medaka, the expression of the macrophage marker,
l-plastin ﬁrst appeared at st22, predominantly in cells in the anterior
region of the embryonic body (Fig. 7A, C), which have been proposed to
be equivalent to the cell population described as cranial primitive
macrophages in zebraﬁsh (Davidson and Zon, 2004; Martinez-Agosto
et al., 2007). Interestingly, although effects on primitive macrophages
were not examined in previous c-myb loss-of-function studies (Greig
et al., 2008; Mucenski et al., 1991; Thompson et al., 1998; Tober et al.,
2008),we found that the expression of l-plastinwas absent at st22-23 in
bef , indicating the defect of primitive macrophages in c-myb null allele
(Fig. 7B, D, F). However, observations on successive stages revealed that
the l-plastin-positive macrophages did appear 3–6 h later, at st24 in bef
(Fig. 7H). The cranial macrophages in bef seemed continually to exist in
the cranial region (Fig. 8B, D asterisks).
Next, we attempted to ﬁnd out whether the deﬁnitive macrophages
were also affected in bef. At, st27 and 32, the expression of l-plastinwas
observed in a “dotted” pattern throughout the yolk sac in the WT
embryos (Fig. 8A, E, I, and C, G, K). However, in bef, the expression ofl-plastin showed a signiﬁcant decrease (Fig. 8B, F, J, and D, H, L). In bef,
most of the l-plastin expression in the posterior region was absent
(Fig. 8B, D, white arrowheads); in contrast, the expression in the
anterior region, which is expected to be the macrophages produced in
the primitive hematopoiesis, kept on remaining in bef embryos though
at a much lower level (Fig. 8B, D, asterisks).
At st32, several noticeable l-plastin expressions were missing in bef
embryos. At the anterior region, concentrated expression was seen in
the 2 distinctive sites (Fig. 8G, black arrowheads), which is expected to
be the future hematopoietic tissues, thymus and pronephros (Fedorova
et al., 2008; Iwanami et al., 2004). In bef, this dense expression was not
observed (Fig. 8H, white arrowheads). In addition, at the caudal area in
WT embryos, the l-plastin expressionwas observed in the ventral side of
the notochord, which is expected to be the circulating macrophages,
(Fig. 8K, black arrow) , on the contrary in bef embryos the expression
was absent (Fig. 8K, white arrow).
Next, to evaluate macrophage differentiation in bef, we carried out
WISH with a pu.1 probe, which detects macrophage progenitors
(Fig. 8M–P). In WT embryos, the expression of pu.1was observed in a
“dotted” pattern at the ventral side of the caudal region of the
embryonic body at st27 and st32 (Fig. 8M, O, black arrowheads). In
bef, the expression of pu.1 was totally absent (Fig. 8N, P, white
arrowheads), indicating that the macrophage progenitors were also
absent in bef.
Fig. 7. Primitive macrophages in bef. Expression of l-plastin, a macrophage marker, in
the early embryonic stages (A-H; yolk-sac removed in “G” and “H”). In WT, the
primitive cranial macrophages appear ﬁrst at st22 (A, C, black arrowhead compared
with white arrowhead in B); whereas in bef, they appear at st24 (H, white arrowhead
compared with black arrowhead in G), indicating delayed emergence of the primitive
macrophage in bef. Scale bars indicate 250 μm.
140 A. Moriyama et al. / Developmental Biology 345 (2010) 133–143Taken together, these results indicated that the in the absence of
c-myb, most of the macrophages and the macrophage progenitors are
lost. However, primitivemacrophages in the anterior region still could
exist, though the timing of their emergence is delayed.
Neutrophils and lymphocytes in bef
Furthermore, we performed WISH with molecular markers for
neutrophils and lymphocytes in bef mutant. The marker we used for
the neutrophils wasmpo1, which is reported to express speciﬁcally in
myelomonocytic lineages (Bennett et al., 2001; Lieschke et al., 2001).In medaka, the mpo1-positive neutrophils also showed a similar
“dotted” expression as the l-plastin (thoughmany fewer “dots”) inWT
embryos (Fig. 9A, E, I and C, G, K). On the contrary, in bef, the
expression of mpo1 was completely absent (Fig. 9B, F, J and D, H, L),
indicating that the production of neutrophils is completely arrested
in bef.
Furthermore, we expected that lymphocytes would show a severe
reduction in bef, based on the studies on mice, which reported the c-myb
dominancy for lymphocyte production (Carpinelli et al., 2004; Greig et al.,
2008; Sandberg et al., 2005). To conﬁrm the lymphocytes in bef, we
examined the expression of rag1, which is reported to be an immature
lymphocyte-speciﬁc marker expressed in thymus of medaka (Iwanami
et al., 2004; Schatz et al., 1989; Willett et al., 1997). In the st39 (9dpf;
hatching stage) embryo of WT medaka, strong expression of rag1 was
observed in the thymus (Fig. 9M, black arrowheads), whereas its
expression was clearly lost in bef embryos (Fig. 9N, white arrowheads).
This result indicates that the production of lymphocytes is arrested in the
absence of c-myb.
To validate these results, we examined the expressions of mpo1 and
rag1 in other embryonic stages and subsequent larval stages with bef
embryos, and observed a complete loss of their expression throughout its
developmental stages (data not shown).
Discussion
In this study, we further characterized Beni fuji (bef), which was
isolated as a medaka mutant with a reduced number of blood cells
(Tanaka et al., 2004). From the positional cloning, we revealed that the
bef mutant had a nonsense mutation in its c-myb gene, resulting in a
truncated protein functionally equivalent to the null state (Greig et al.,
2008; RamsayandGonda, 2008). Thisbefmutant is theﬁrst viable c-myb
mutant in teleosts that can develop and survive throughout the
hematopoietic stages. In order to understand the phenotype of bef
mutant, we carried out the ﬁrst analysis of primitive and deﬁnitive
hematopoiesis in medaka.
Expression of hematopoietic markers revealed that the primitive
hematopoiesis takes place at st20-24, at the bilateral stripes of anterior
and posterior lateral mesoderm. Anterior macrophages and posterior
erythrocytes were observed, which fully coincide with the zebraﬁsh
primitive hematopoiesis (Carradice and Lieschke, 2008; Davidson and
Zon, 2004; Hsia and Zon, 2005).The deﬁnitive hematopoiesis inmedaka
takes place on the stages subsequent to st23 (41hpf; 12-somite stage).
The ﬁrst deﬁnitive progenitors are expected to appear at the site dorsal
to the ICM.We termed this dorsal site as the deﬁnitive area, basedon the
result that the α-globin expression was totally lost.
We found that c-mybwas expressed throughout the early stages to
mid-developed embryonic stages: in the anterior and posterior lateral
mesoderm,whereprimitivehematopoietic progenitors rise, aswell as in
the prospective deﬁnitive region in the late-stage embryo, located at the
vicinity of dorsal aorta.We surmise that this late c-myb expression is the
medaka analogoue of zebraﬁsh EMPs or AGM (Bertrand et al., 2008;
Bertrand et al., 2007; Bertrand and Traver, 2009; Davidson and Zon,
2004; Hsia and Zon, 2005; Lin et al., 2005), however, further
characterization is necessary and these tissues are yet to be deﬁned in
medaka. From the expression pattern of c-myb, we expected that the
absence of c-myb would show defects not only in deﬁnitive hemato-
poiesis but also in primitive hematopoiesis.
Based on the examination of l-plastin and α-globin, we found that bef
mutant also demonstrated defects in the primitive hematopoiesis. We
observed a diminution of primitive erythrocytes and a delay in the
emergence of primitivemacrophages in the bef embryos. Furthermore, in
bef embryos, a group of erythrocytes continued to persist in the ICM . One
possibility to explain this phenomenon is that, due to the absence of
c-myb, the primitive erythrocytes cannot fully differentiate, which results
to alter their behaviors in migration. However, further investigation is
required to explain the exact reason. Another possibility, which we
Fig. 8. Deﬁnitive macrophages in bef. Expression of l-plastin at st27 and st32, observed at the lateral, anterior, and posterior sites (A–L), and expression of pu.1, a marker of macrophage
progenitors (yolk-sac removed in “M–P”).Mostof the l-plastinexpression inbef is absent (white arrowhead inB,D, comparedwith black arrowhead inA,C),while the l-plastin showsdense
expression (G arrowheads, K arrow). The cranial macrophages in bef seemed to continually exist in the cranial region (B, D asterisks). The pu.1expression in bef is completely lost
(white arrowhead in N, P, compared with black arrowhead in M, O), suggesting the absence of DP-derived macrophage progenitors in bef. Scale bars indicate 250 μm.
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cannot be initiated, resulting in the continuation of the primitive
hematopoiesis, thus, the primitive and the deﬁnitive hematopoiesis are
linked and that the transition may be regulated by c-myb.
Regarding the reports inmousehematopoiesis, the c-mybexpression
has not beenobserved in theprimitive erythrocytes andmacrophages in
mouse, and c-myb-deﬁcientmouse showed no defects in their primitive
erythrocytes or macrophages (Mucenski et al., 1991; Palis et al., 1999;
Tober et al., 2008). These data are in contrast to our data, and to thestudies in zebraﬁsh where c-myb expression is observed in their
primitive erythrocytes (Hsia andZon, 2005; Thompsonet al., 1998). This
disparity led us conjecture that the primitive cells termed in the mice
may be different to that termed in medaka and zebraﬁsh, although
further validation is required.
On the contrary, severe defects have been reported in the c-myb-
deﬁcient mouse indicating the cessation of the deﬁnitive hematopoi-
esis from HSCs (Greig et al., 2008; Mucenski et al., 1991; Tober et al.,
2008). This concurs with the result in bef, i.e. the signiﬁcantly
Fig. 9. Neutrophils and lymphocytes in bef. Expression of mpo1, a neutrophil marker, at st27 and st32, observed at the lateral, anterior and posterior sites (A–L), and expression of
rag1, a lymphocyte marker, in st39 (9dpf; hatching stage) embryo (M, N). bef completely lacks neutrophils and lymphocytes (white arrowheads in N, compared with black
arrowheads in M). Scale bars indicate 250 μm.
142 A. Moriyama et al. / Developmental Biology 345 (2010) 133–143decreased erythrocytes and macrophages, and the complete loss of
neutrophils and lymphocytes.
Taken that the terminally differentiated blood cells were impaired
in bef, we attempted to examine whether the hemogenic progenitors
were likewise affected. To examine the vascular cells, we crossed bef
with the ﬂi1-GFP and found that the vessels in bef had relatively
normal morphology (Supplementary Figs.1A, B), suggesting that the
in bef, the vascular cells are not severely affected. We also carried out
the WISH analysis of c-myb in bef mutant and found out that the bef
embyos sustained expression of c-myb in the deﬁnitive area
(Supplementary Figs.1 E), which may indicate the existence of
deﬁnitive stem cells in bef mutant.
Based on all our ﬁndings taken together, we propose a new role for
c-myb, i.e., its involvement in primitive hematopoiesis. Furthermore,
our data potentially demonstrate a link between primitive anddeﬁnitive hematopoiesis in the aspect of the continuous c-myb
expression.
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